Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.

J

JAMA

@JAMA_current · X

In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterioration over 15 days vs placebo. However, the study is limited by a small sample size & short follow-up https://t.co/XPnsd0YrJ8

P

PrimulaClinic

@PrimulaClinic · X

W każdym z tych badań wykazano skuteczność fluwoksaminy w dawce 2 x 100 mg. Są to dobrze zaplanowane randomizowane badania: 1. https://t.co/5eRQ7EaZ8u 2. https://t.co/0r2Ggptn2c oraz metaanaliza: 3. https://t.co/3gXZscr1XB 3/n https://t.co/9kNd1lq2F2

DR

Dr. Gadala Srinivasa Rao

@drgsrao · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/hFeIsgQPbK

S

stefanie

@Quo_vadis_BRD · X

4/ … da er ein gewisses antientzündliches Potential aufweist und auch wirksam sein soll gegen den sog. #Zytokinsturm. So sollen bereits die Ergebnisse dieser Studie aus 11/20 (sic!) sehr vielversprechend gewesen sein: https://t.co/qXprZLGC0d https://t.co/A2z4tIslMd

AM

Angela Reiersen, MD, MPE

@AngelaReiersen · X

@farid__jalali @DrEricDing @dianaberrent @WesElyMD @farid__jalali is correct. I am senior author on the Lenze et al. Paper in JAMA. https://t.co/PKYcUWjiSk https://t.co/fEXzxLeItG

S

stefanie

@Quo_vadis_BRD · X

5/ Das @Dt_Aerzteblatt hatte in 10/21 Ebenso über Erfolge des Wirkstoffes im Kampf gegen #Covid19 berichtet, und im Jahr 2022 fand #Fluvoxamin auch Eingang in … https://t.co/qXprZLGC0d https://t.co/4sCHiRVuVt

L

Lucibee

@_Lucibee · X

And it's not just TCAs, but SSRIs too. Fluvoxamine was identified quite early on as a potential treatment for COVID-19, because of its antiviral and anti-inflammatory effects. https://t.co/wuPAHy4coq https://t.co/w4nNfinMyH https://t.co/fJIPiLIdB0

WN

Woody Nist

@Woodynist · X

2/2 En revanche Covid-OUT, négatif pour Fluvoxamine? 50mg X 1j + (2X50mg X 14j) ce n'est pas pareil que (100mg X 3) X 15J : https://t.co/ygmwg4k6Kh @AngelaReiersen Le dosage, ça compte, les (

WN

Woody Nist

@Woodynist · X

1/2 Favorable Antiviral Effect of #Metformin on SARS-CoV-2 Viral Load in a Randomized Placebo-Controlled Clinical Trial of #COVID19 + "Metformin is PLEIOTROPIC with OTHER ACTIONS that are relevant to COVID19 PATHOPHYSIOLOGY" @HAS_sante @ansm @D_Deplanque https://t.co/ygmwg4k6Kh

FG

Facts Are Good

@Facts_R_Good · X

@BigBlockBuickGS @sjs856 @HamHead5813 Oh, look. A trial on fluvoxamine from 2020. https://t.co/1Rs5Lvh52B https://t.co/LuNFyXCirg

U

Uncover 007

@uncover007 · X

@RWittenbrink Soll ja auch bei akuter Infektion gut wirken: https://t.co/nX9tTqPLmb

AC

a_chtung

@a_chtung · X

hey! https://t.co/ZDXEdB3cDH, https://t.co/ODB0F4cqIt, https://t.co/1ngGG5Ptsa https://t.co/TcKFCn1Qqx

K

Kapinos

@schwester_gk · X

RT @Quo_vadis_BRD: 5/ Das @Dt_Aerzteblatt hatte in 10/21 Ebenso über Erfolge des Wirkstoffes im Kampf gegen #Covid19 berichtet, und im Jahr…

K

Kapinos

@schwester_gk · X

RT @Quo_vadis_BRD: 4/ … da er ein gewisses antientzündliches Potential aufweist und auch wirksam sein soll gegen den sog. #Zytokinsturm. S…

VJ

❤️ & `Visibility Filtering` .~* #julianIsINNOCENT

@rhabarbeer · X

RT @Quo_vadis_BRD: 5/ Das @Dt_Aerzteblatt hatte in 10/21 Ebenso über Erfolge des Wirkstoffes im Kampf gegen #Covid19 berichtet, und im Jahr…

VJ

❤️ & `Visibility Filtering` .~* #julianIsINNOCENT

@rhabarbeer · X

RT @Quo_vadis_BRD: 4/ … da er ein gewisses antientzündliches Potential aufweist und auch wirksam sein soll gegen den sog. #Zytokinsturm. S…

NN

Nomen Nominandum

@NihilNescio · X

RT @Quo_vadis_BRD: 5/ Das @Dt_Aerzteblatt hatte in 10/21 Ebenso über Erfolge des Wirkstoffes im Kampf gegen #Covid19 berichtet, und im Jahr…

NN

Nomen Nominandum

@NihilNescio · X

RT @Quo_vadis_BRD: 4/ … da er ein gewisses antientzündliches Potential aufweist und auch wirksam sein soll gegen den sog. #Zytokinsturm. S…

S

stefanie

@Quo_vadis_BRD · X

5/ Das @Dt_Aerzteblatt hatte in 10/21 Ebenso über Erfolge des Wirkstoffes im Kampf gegen #Covid19 berichtet, und im Jahr 2022 fand #Fluvoxamin auch Eingang in … https://t.co/qXprZLGC0d https://t.co/4sCHiRVuVt

S

stefanie

@Quo_vadis_BRD · X

4/ … da er ein gewisses antientzündliches Potential aufweist und auch wirksam sein soll gegen den sog. #Zytokinsturm. So sollen bereits die Ergebnisse dieser Studie aus 11/20 (sic!) sehr vielversprechend gewesen sein: https://t.co/qXprZLGC0d https://t.co/A2z4tIslMd

猫

猫やで

@7YzzjuywccS3RwK · X

RT @ygjumi: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial https://…

PR

Prof. Rod

@rodedc1 · X

Just as this paper stated 3 years ago!! ... https://t.co/580sPUo18Q

MB

Michael Bertakis

@MICHAELBERTAKIS · X

Σύγκριση της αποτελεσματικότητας της φλουβοξαμίνης έναντι εικονικού φαρμάκου ως προς το χρόνο ανάρρωσης σε εξωνοσοκομειακούς ασθενείς με ήπια προς μέτρια νόσο Covid-19 https://t.co/K0CkXuVZJG https://t.co/dtE72hPCFK

RH

RB Long Hauler

@rb_long · X

@GrowingJohnsons @DrCanuckMD You don’t understand the mechanism of action. It’s had very good results in multiple trials at 100mg bid. https://t.co/wUOL02ixUi https://t.co/QLcrjxukgw

AM

Angela Reiersen, MD, MPE

@AngelaReiersen · X

If I had not come across that 2019 article about S1R-related anti-inflammatory effects of fluvoxamine in mice, @EricLenze2 and I might not have had the idea to do this RCT looking at fluvoxamine as a treatment for COVID-19. https://t.co/PKYcUWjQHS

Z

Zenelan

@realZenelan · X

@RolandBakerIII @Ellaj26927542 @kellywind @Nk9992Nk I thought their idea with fluvoxamine was the Sigma-1 receptor agonist pathway: https://t.co/MVG7m4uQ2g

WN

Woody Nist

@Woodynist · X

@Spinest2017 @Jonath9999 @winslow_la @SaiyanBio @APHP @Inserm Ou encore : “Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19“ Qui, parmi vous, a mieux que ces deux articles sur la vitamine D ou la fluvoxamine, comme témoignage de son "vécu" de médecin ou de preliminary study? https://t.co/UhzZDtwqe6

NP

Nicolas Hoertel, MD, MPH, PhD

@HoertelN · X

@cialdella01 @saada_vsaada @lonnibesancon JAMA : https://t.co/fXEr6o6Eoz Lancet Glob Health: https://t.co/lsSEQUVnJo Lancet Glob Health (ré-analayse pour l’outcome principal de l’essai Paxlovid): https://t.co/NceDsJpw62 NEJM (essai faible dose chez patients en surpoids ou obèses, négatif): https://t.co/23zDz0UDFe

JS

Junta precz! #Nawrocki2025 #SiećPatriotów

@Qwas12306144949 · X

@nazgul43 @SteniaSahaj @Rose73389488 @ankapodlasianka nie rozumiem o co chodzi. O leczenie covid? o terapii wiadomo od 06.2020, publikacja 11.2020. Lek dopuszczony w 1984, tani jak barszcz, bezpieczniejszy od paracetamolu. Bardzo skuteczny. https://t.co/xslp7LU5W3

CM

Celeste Kenney, NCC, MS

@celestial_bean_ · X

@TroyDellOrfano @NastyProud @RepGosar • Sources: •

J

jazminek

@jazminek18 · X

RT @basiukiewiczpaw: W każdym z tych badań wykazano skuteczność fluwoksaminy w dawce 2 x 100 mg. Są to dobrze zaplanowane randomizowane bad…

EJ

Ela Jagiełło

@ElaJagie · X

RT @basiukiewiczpaw: W każdym z tych badań wykazano skuteczność fluwoksaminy w dawce 2 x 100 mg. Są to dobrze zaplanowane randomizowane bad…

P

PrimulaClinic

@PrimulaClinic · X

W każdym z tych badań wykazano skuteczność fluwoksaminy w dawce 2 x 100 mg. Są to dobrze zaplanowane randomizowane badania: 1. https://t.co/5eRQ7EaZ8u 2. https://t.co/0r2Ggptn2c oraz metaanaliza: 3. https://t.co/3gXZscr1XB 3/n https://t.co/9kNd1lq2F2

AM

Angela Reiersen, MD, MPE

@AngelaReiersen · X

@M_Ben_Yehuda @RonJCarson1 @HoertelN @Bradley_A_Fritz @EricLenze2 @farid__jalali Already got a few RCTs and more are recently completed or ongoing. I published the first in November 2020. https://t.co/PKYcUWjiSk

M

Marcin

@ZarzadcaTrzody · X

@AgnieszkaSzust3 Strasznie szkoda tej fluwoksaminy, to badanie dawało nadzieję -> https://t.co/9FfhonH8ID. Najwyraźniej za mała grupa pacjentów (n=152) dała niewymierne wyniki.

A

Amos

@millenamos · X

@ChrisWr29239481 @AlbaAdventureNY @CMichaelGibson This is the Lenze et al study I was referring to that involved 100mg : https://t.co/jZN6DRw27Q Where did you see 300mg?

MJ

Martin Juhl

@MartinJuhl2 · X

Derefter kom det første RCT med fluvoxamine ud ”STOP COVID 1” Det skal dog nævnes at de kun fulgte patienterne i 7 dage og der efter 7 dage var to i behandlingsgruppen der blev indlagt https://t.co/sEYvPz15ug 12/19 https://t.co/LqMlzzMYmJ

T

theoy991

@theoy991 · X

@NotSoDarnSure @SenorCampana @walidgellad No you’re thinking of paxlovid. Fluvoxamine (Luvox) is a cheap generic antidepressant. Several studies have shown a short course of Luvox in outpatient Covid markedly reduced risk of progression to hospitalization. https://t.co/Vd6LFNiXOU https://t.co/TBtgbvY9f4

TJ

TOM&JERRY

@PATRIZI21156466 · X

RT @Truthseeker2213: @drbeen_medical Sack the criminals at the FDA. Charge them for crimes against humanity. 2 important clinical trials s…

LV

L'Italia Vera ®️+

@SoniaLaVera · X

RT @Truthseeker2213: @drbeen_medical Sack the criminals at the FDA. Charge them for crimes against humanity. 2 important clinical trials s…

T

Truthseeker22

@Truthseeker2213 · X

RT @Truthseeker2213: @drbeen_medical Sack the criminals at the FDA. Charge them for crimes against humanity. 2 important clinical trials s…

T

Truthseeker22

@Truthseeker2213 · X

@drbeen_medical Sack the criminals at the FDA. Charge them for crimes against humanity. 2 important clinical trials show fluvoxamine is effective. The Lancet one showed fluv reduced C19 hospitalizations by 2/3 & deaths by >90 percent. https://t.co/SUQSfD96Co https://t.co/3SN5NLwAPf https://t.co/eLAG1ZsXi5

AF

Amol D. Kothalkar MBBS, MD, DNB(Cardiology), FIC

@hypomaniac07 · X

@fluvoxamine https://t.co/anZjwBXkvN

MH

Miss H

@ReinaBesties · X

This is the protocol that inspired me to try #fluvoxamine https://t.co/J5ub7GzBwo This video explains why it's helpful (watch it!): https://t.co/yENGXLrnXb These are studies regarding its effects with covid: https://t.co/DQrCC5RKvZ https://t.co/ounaFjihM0 https://t.co/ikL9vRNhyA

AM

Angela Reiersen, MD, MPE

@AngelaReiersen · X

@farid__jalali @DrEricDing @dianaberrent @WesElyMD @farid__jalali is correct. I am senior author on the Lenze et al. Paper in JAMA. https://t.co/PKYcUWjiSk https://t.co/fEXzxLeItG

Z

Zap

@zap_lock · X

@GnosticCinema @CherryMcG23 @ScottAdamsSays @WSJ Not such a good study as is beginning of Covid. Also I've given you quite a few studies showing the effectiveness of Fluvoxamine. I'm off to work now, I'm sure you're big enough to do your own research. https://t.co/FUhZEzuxpa

IM

Iain Mulady

@IainMulady · X

@RobertWmRuedii @BadVaccineTakes Fluvoxamine actually works though. https://t.co/D0unFwdJ5n repeated https://t.co/8TgJ0vAMrE

LR

Lilka #Nawrocki2025 #ReparationforPoland

@lilka_nn · X

@basiukiewiczpaw a Pan oczywiscie NIE JEST zainteresowany LECZENIEM Covid, lepiej bic piane. COvid to choroba trwajaca kilka dni do dwoch tygodni, pod warunkiem, ze jest leczona FLUWOKSAMINA. Wiemy o tym od listopada 2020 https://t.co/9QnXizp5cH

LR

Lilka #Nawrocki2025 #ReparationforPoland

@lilka_nn · X

@Magorza84783552 @basiukiewiczpaw a skad te dane? Bo wg publikacji w JAMA obnizyla ryzyko hospitalizacji o 100% https://t.co/9QnXizp5cH podobnie zreszta jak w tym badaniu https://t.co/QKkmB6QQmG

DC

Daniel Corcos

@daniel_corcos · X

@Woodynist @philippefroguel @DocCyrReb88 @stephensenn Je pensais que c'était par des RCT: https://t.co/Lts6GQkbkU

TT

took14theteam

@took14theteam · X

RT @lilka_nn: @zweinebelkerzen could you give a link? I was not PCR tested, just my AB was 3 weeks after vaccination > 300 (cut - off 25).…

LM

Loofymectin aka Jan Masleid

@loofymectin · X

@FinkelsteinsKid @AngelaReiersen @compassion_ate_ https://t.co/bXz9Dt4Tyg

LM

Loofymectin aka Jan Masleid

@loofymectin · X

@FinkelsteinsKid @AngelaReiersen @compassion_ate_ Nov. 2020Eric J. Lenze, MD1; XX Mattar, MD2; XX F. Zorumski, MD1; XX Stevens, BA1; XX Schweiger1; XX Nicol, MD1; XX Miller, AB3; XX Yang, MPH, MSIS1; XX Yingling, MS1; XX S. Avidan, MBBCh4; Angela M. Reiersen, MD, MPE1 JAMA. 2020;324(22):2292-2300. doi:10.1001/jama.2020.22760

D

Daniel

@crunchyd4d1 · X

@quintocreciente @azoteprogresia @Pablolinde Otro tratamiento, por si acaso le interesa aplicarlo para salvar vidas, en vez de seguir protocolos. https://t.co/fYyGoUSRiB https://t.co/8GyeOMAmH9

X

x

@illary_1493 · X

@frankedgarbass @rmapalacios Sabías que existen rigurosas investigaciones científicas sobre la fluxoxamina y la vitamina d, ampliamente usados de manera informal por médicos. La revista científica American Medical Association mostró resultados prometedores: https://t.co/uDKNf7fMlF

MN

Mental Healthcare NOW!!

@MartyBevan1 · X

@coopSpeak @EricaEhm Has she done screeners for depression? That'll stop you getting out of bed and feels like fatigue. Also they are treating COVID with an antidepressant now because it's also an anti-inflammatory. https://t.co/TT0LwgfZkL Perhaps that's something to look into?

SA

sergio As

@SUpforit · X

@Albiku @MatiMatarredona https://t.co/CTEOD6jDZc

J

John

@jhnamaral · X

Effect of Fluvoxamine vs Placebo on Clinical Deterioration in Outpatients With Symptomatic COVID-19 https://t.co/hhTsJ8CtkI via @JAMA_current part of @JAMANetwork

MS

Michael Serdikoff

@MSerdikoff · X

@IvorMectin1 https://t.co/yAK192Ya2S

WN

Woody Nist

@Woodynist · X

@mortimer6969 @Zulu18360299 @GloPID_R L'OMS, informée des bons résultats de la fluvoxamine, aurait au moins pu la mettre dans Solidarity en 2021. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial - (décembre 2020) https://t.co/ygmwg4k6Kh

MF

Maples the Syrup Frog

@Maples46014332 · X

https://t.co/5CM6IV1EYS

GM

Giovanni Landoni, MD

@giovannilandoni · X

Everything started with this trial: clinical deterioration occurred in 0 of 80 patients in the #fluvoxamine group and in 6 of 72 patients in the placebo group (absolute difference, 8.7% [95% CI, 1.8%-16.4%] https://t.co/nAAZS2KhcC

JS

Juan Senior

@jsenior64 · X

@lapestilencia @MinSaludCol @Fruizgomez @acinnacional @acinantioquia @solsilvanazb @FGarridoB @ReumatologoLFP @FerSuarezMD @edisonhoy @gerardoperilla @DaJoGonzalezQ

JS

Julien Sotttet

@Moonwalker33333 · X

@Saiji_Tv @nathanpsmad Pas sur que vous ayez les capacités pour comprendre tout ça mais bon... https://t.co/7ahcsJIXs5

LL

Lecomte Laurent

@larent17 · X

@HSkyfleet @marcoux74 @raoult_didier https://t.co/LF0X14OREi. Ce n’est pas parce que tu n’en entends pas parler que ça n’est pas utilisé quelques part dans le monde

B

BarkingMadMD

@3GHtweets · X

@canonreedit @MariaBartiromo @SundayFutures @FoxNews @PierreKory @SenRonJohnson @TuckerCarlson @Covid19Critical @AAPSonline As w/ L-T use of any SNRI. Fluvoxamine is typically a 14-day course for treatment of CV19. In none of the clinical trials was impotence reported as an AE by study participants. See eg. https://t.co/acV3QxCYWR or https://t.co/KtJlsY45gh Please don't spread misinformation!

TP

Talia Wegman MD, PhD

@taliawegman · X

@DiegoVacas https://t.co/nOT2PtuFOp

DD

David Clinkard M.D

@DavidClinkard · X

@Cheesy16291157 @DavidJuurlink @ENirenberg Two well done trials in reputable journals are very positive. https://t.co/rCrzVHlQsS https://t.co/3zFMtewQS0

C

Chris

@ChrisIsDriven · X

Ontario MD told me their hospital was finally informed of fluvoxamine approval for c19. Presenter claimed it's not effective though. Typical MD ignorance. https://t.co/C0l8FJahPC https://t.co/QiEbDsMose This is for just ONE intervention (drug).

JS

Juan Senior

@jsenior64 · X

@Everferney03 @Sandrau43858348 https://t.co/S58MSo6ASs

DD

David Clinkard M.D

@DavidClinkard · X

@jonathan_ploski @pdhsu @zchagla The jama study looked at anxiety.. Supplement 2. No difference that I see. When I start SSRIs on pts, I usually follow up in 2 weeks, is there evidence to suggest suicide risk is sig increased in first 10 days? https://t.co/rCrzVHlQsS

FM

Feda Mecan

@just1ofyou · X

@Jason Who said it's not talked about or used? https://t.co/wm1t8r7bSh

J

Jeff

@BlueLionBlog · X

@SkepticalMutant @SandraHosford @keithccurtis @KStateTurk @crabb_vicki @TheFrankmanMN @cappsie @ChrisJohnsonMD @Monstercoyliar @FrankDElia7 @TeddyFreddy11 @TruthTwt @ellethejambo @doritmi @KassandraSeven @BurgerLab12 @Juanita87722370 @BGLTHMND @WendyOrent @krebiozen @immunotoxPhD @painless42 @LazarusLong13 @Twanky_Resists @lizditz @R_Good_Fellow @mimetic_ @kidoctr @drhenrymyman @kfunk937 @Felicea @CBereel @mcfunny @2ManyOfUs @BetteanneCamag1 @hempyhope @Landau_18901 @Rogue_Soc_Psych @natedoromal @GeoffSchuler @Rosewind2007 @chaoticsx2 @djrazorgirl @KatLaRue7 @ianfmusgrave @microRNApro @LaLaRueFrench75 @LynnleeMavakay @TinFoilAwards @jkellyca https://t.co/SHQezjnnSi https://t.co/pxOyGdtDnt

AF

Angry Fleas

@AngryFleas · X

@BlackSh96578247 @PRider1980 @MrScaryPFD @JesseKellyDC Here's a non-Lancet source on fluvoxamine. Would it be OK if fluvoxamine worked against COVID? https://t.co/3nCdOCkj0l

KY

Kaporal Yoda

@Stephan67358673 · X

@Nodo23049099 @Yves_Doessant @PosoccoN @pude32 @nathanpsmad et il y a une autre RCT dans JAMA: Randomized trial with 152 COVID adult outpatients and symptom onset in 7 days, clinical deteriora° occurred in 0 patients with FLUVOXAMINE vs 6 patients with placebo over 15 days, a statistically significant difference https://t.co/k2Zo7UP0Wm

FF

Falando Farmacologia

@FFarmacologia · X

Os resultados do estudo STOP COVID foram publicados no link: https://t.co/mcl8op8qbO

GM

Gilad Wasserman, DMD/MSc

@giladwas · X

שאלה - האם מע׳ הבריאות שלנו היא לא המקום המושלם לעשות מחקר רטרוספקטיבי על Favoxil למנוע התדרדרות במקרים של COVID? לבחון אירועים של אשפוז/הנשמה/מוות במטופלים שגם ככה נוטלים את התרופה ונדבקו? @RanBalicer @HagaiLevine @gilboa_mayan https://t.co/fWzqkQQZuY

JG

Jay Grant

@J4yGrant · X

@Chrisp_W4 @TheStallionMang @iAmericatoo @karinatheslayer "Fluvoxamine may prevent clinical deterioration by stimulating the σ-1 receptor, which regulates cytokine production." Positive result even if small study, seems to warrant further study. https://t.co/YXXW7ed3JN

AG

Alan M. Goldberg

@AlanMGoldberg · X

Fluvoxamine is a successful therapeutic for Covid. Have you heard this? A subsequent study published in Lancet found same. Democrats won’t tell you because they support only vaccines, to control you. https://t.co/0gbWgDrrR1

C

CountryoverParty

@brayfield_agk · X

@TedBrogan5 @farid__jalali @IrishHandshake @Birdsonbranch1 @emdrich80 Dude, it’s sad seeing you arguing with professionals, having tweet fits about things you clearly know nothing about. Many peer-reviewed Fluvoxamine RCTs over 13 months on the 1st page of a Google search

AF

Amol D. Kothalkar MBBS, MD, DNB(Cardiology), FIC

@hypomaniac07 · X

@kposendek @ABsteward https://t.co/anZjwCenxN https://t.co/ASP7vJUfaQ https://t.co/C22pi58GGx

に雑

にゃうーん(雑多アカ)

@PdjowszfAFhNP6t · X

@kasumikasumin25 こんばんは。 https://t.co/dn8oz56AeG サイトカインストームの抑制…重症化予防…ですかね。感染後の服用でも遅くはなさそうな気がします。 この手の薬はやめ時に断薬症状が出やすいのが難点ですね。

BV

B6VECcNetVjoam7

@B6VECcNetVjoam7 · X

@BB45_Colorado @heartkirakirha COVID-19の外来患者におけるフルボキサミン対プラセボ の有害事象になります。（JAMA） https://t.co/lbjegAIzxb https://t.co/GdB8i9wRZ2

FS

foggy forest sea

@foggyforestsea · X

@peterwildeford Here's one RCT. Note that some people with pre-existing conditions were excluded - if I had such a pre-existing condition, I'd be wary. https://t.co/FlU1rlomXF

LA

Liberatarian - freedom to all

@darzil2013 · X

@adriandix @NicholasSimons When are you making therapies available (monoclono-antibodies)? It is clear the shots are not stopping the transmission of Covid. Fluvoxamine reduced hospitals visits by 66% and deaths by 91%. https://t.co/xgzd879ns4

VT

Vlad Tepes

@Shared_Boat · X

@Jim__Jackson Are you using fluvoxamine? https://t.co/rYXiVCPajb

BU

⭐️ Ben Ur ⭐️

@MrUrben · X

@amelie_for_you @OJBoyau @lebon80 @dperetti @Moonwalker33333 @MartinBlachier @Sonic_urticant @LacombeKarine1 @LehmannDrC @MathieuMolimard @sudokuvariante Vous parlez du JAMA et du Lancet ? https://t.co/2k9S1YVR9r https://t.co/USqm0s1MaT

JS

Julien Sotttet

@Moonwalker33333 · X

@amelie_for_you @OJBoyau @MartinBlachier @Sonic_urticant @LacombeKarine1 @LehmannDrC @MathieuMolimard https://t.co/7ahcsJIXs5

EM

Ernesto de Bernardis, MD

@debe · X

Le attuali evidenze sulla fluvoxamina nella terapia precoce del Covid: https://t.co/V9bsn3Au38 https://t.co/EsbRyifhHr https://t.co/xdhbcYeJI5 Review in https://t.co/1mAbkn3Php La fluvoxamina è un farmaco vecchio, e quindi ben conosciuto, e di basso costo.

B

Bob

@fluxcapdoodah · X

RT @AngelaReiersen: https://t.co/PKYcUWjiSk

TB

Torsen Brems

@TorsenBrems · X

RT @dr_larryi: This is a follow up to another smaller randomized placebo controlled trial in JAMA with similar results https://t.co/EP2PvRO…

I

Iza

@Iza03217914 · X

RT @dr_larryi: This is a follow up to another smaller randomized placebo controlled trial in JAMA with similar results https://t.co/EP2PvRO…

DI

Dr. Larry Istrail

@dr_larryi · X

This is a follow up to another smaller randomized placebo controlled trial in JAMA with similar results https://t.co/EP2PvROupS

AM

Angela Reiersen, MD, MPE

@AngelaReiersen · X

https://t.co/PKYcUWjiSk

W

Woodpecker

@KWS99 · X

@mikebarnkob @resus_man Når du en dag har tid, må du gerne kommentere på disse - lagt som screendumps https://t.co/1WM6BByDes https://t.co/Q6lB9hxyj8 https://t.co/hJFSSyPqvx & https://t.co/4XhsNiZW6n https://t.co/vCLB8vc5UH https://t.co/A7MfZccPiL

J

Joafer11

@joafer11 · X

Fluvoxamina en covid19 https://t.co/ZjkQnO8wVZ

AP

andreas.karatassios-peios

@AndreasPeios · X

@ForBetterSci https://t.co/DM0B6Zbj4R https://t.co/wPgDkUmJRm https://t.co/A6NBMHmXgL ok i will sue the hospital in an american district court, not in an court in germany

DM

Dr. Eric Oh So Good MD

@EdoajoEric · X

@SallySamsara Do u read clinical trials? https://t.co/aswpjmRHc2

LR

Lilka #Nawrocki2025 #ReparationforPoland

@lilka_nn · X

@zweinebelkerzen could you give a link? I was not PCR tested, just my AB was 3 weeks after vaccination > 300 (cut - off 25). And i had long- covid symptoms, which stopped about 10 days after fluvoxamine, but i felt better after 2 days. https://t.co/JvGIES1JXm

KC

Kai Chiu

@KaiChiu1947 · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial https://t.co/ppPxZwRG6P

E

emu

@wordsinusername · X

@AngelliAngelo @danaparish @LauraMiers Very hard to get monoclonals for average person. But fluvoxamine is an antidepressant, and who isn’t depressed from Covid? https://t.co/N2bqlRXSIJ

E

emu

@wordsinusername · X

https://t.co/N2bqlRGhRb

E

emu

@wordsinusername · X

@AlpertMadeline @LauraMiers Try getting Fluvoxamine? It is research based, apparently helps fight Covid https://t.co/N2bqlRXSIJ

KY

Kaporal Yoda

@Stephan67358673 · X

Follow the Science, not the media: Randomized trial with 152 COVID adult outpatients and symptom onset in 7 days, clinical deterioration occurred in 0 patients with FLUVOXAMINE vs 6 patients with placebo over 15 days, a statistically significant difference https://t.co/k2Zo7UP0Wm

AS

Ali Sahabia

@SahabiaAli · X

RT @sudokuvariante: J'ai oublié de mentionner votre omission de la fluvoxamine, dont l'efficacité a été prouvée par des études compatibles…

FS

Fred Stalder

@sudokuvariante · X

J'ai oublié de mentionner votre omission de la fluvoxamine, dont l'efficacité a été prouvée par des études compatibles avec le degré de scientisme de l'élite médicale occidentale: https://t.co/ea8FuvvnuX https://t.co/1VvVmczHOO

BC

BS Crusher

@BSCrusher1 · X

Fluvoxamine vs covid. November 2020' Lenze et all. "It works" https://t.co/cXNGJc0FF7 Year later https://t.co/Vb9eVizkUe "Fluvoxamine could help in covid." And silence since. No sense on rushing these things isn't it @sajidjavid and @BorisJohnson ? https://t.co/66srhwbwU1

SM

Sean Ziegler, MD

@seanzieglermd · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/ILUrBBXxEq

Nל

Noam Leviatan נעם לויתן

@Noams_Ark · X

מאחר שאחת ההשערות היא שהנזק בחולים קשים בקוויד-19 נגרם מתגובה דלקתית מוגזמת החליטו לבדוק את התרופה בניסוי קליני. התוצאות של ניסוי קליני ראשון קטן היו מבטיחות (https://t.co/6TFNnLtU8x), ועכשיו גם של ניסוי ה-TOGETHER הגדול יותר (https://t.co/zkTXMiy1tJ) 3/7 https://t.co/2WwsGiVxNH

M

movedoc

@movedoc · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical T… https://t.co/ObM4k5xzjz

C

ChristIsLord

@StJosephTOD · X

Wow, check out this study on a common SSRI. Possible Covid therapy? If it’s readily prescribed for mental health, why not for covid? #covidtherapy #medicine #earlytreatment https://t.co/ckfh8gYPiE

JB

Jesus Ramirez-Bermudez

@JRBneuropsiq · X

@PloederlM 6) Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial https://t.co/u15uXqUFEl

C

Covidhelpinghand

@DshPharm · X

RT @ivermectincovid: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 #Fluvoxamine #Placebo #Dete…

AH

Antiviral Store | Cancer | HIV

@antiviral_med · X

RT @ivermectincovid: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 #Fluvoxamine #Placebo #Dete…

JA

John Amoroso

@JohnAmoroso7 · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/zc9VFzvkrt

PK

Pharmacare | Ziverdo Kits

@Pharmacarestore · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 #Fluvoxamine #Placebo #Deterioration #ivermectine #coronapas #Corona #Covid_19 https://t.co/mHE0j8Z1uj

AH

Antiviral Store | Cancer | HIV

@antiviral_med · X

RT @DshPharm: Fluvoxamine vs Placebo and #clinical Deterioration in Outpatients With Symptomatic #COVID19 Randomized #clinicaltrials #medi…

SB

SL News RT Bot

@SLNewsRTBot · X

RT @DshPharm: Fluvoxamine vs Placebo and #clinical Deterioration in Outpatients With Symptomatic #COVID19 Randomized #clinicaltrials #medi…

C

Covidhelpinghand

@DshPharm · X

Fluvoxamine vs Placebo and #clinical Deterioration in Outpatients With Symptomatic #COVID19 Randomized #clinicaltrials #medicine #Australian #australialockdown #SICK #COVID19LK https://t.co/QYWxAUUb3P

SB

Stephen Ralph MD ABIM DipABLM BCEM

@sralphmd · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 : small november 2020 study being studied in larger cohort being reported next month ( repurposed old obsessive-compulsive medication …) https://t.co/ThL5heuXz9

佐

佐藤

@gp32er · X

RT @ygjumi: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial https://…

ア

アッシュエイジ

@zinyo_o · X

RT @ygjumi: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial https://…

SH

Sandro Herek

@sandroherek · X

@DemetrioValdir @OnurbMilk @aquicedexa @_Reithe @adilsonhefler @secomvc Fluvoxamina https://t.co/PEfB762YFI Dutasterida https://t.co/pvActePP8v Proxalutamida https://t.co/otMrKfmOrZ HCQ + Colchicina https://t.co/S2aRRFVrCs

YG

yumi ＠gj

@ygjumi · X

RT @ygjumi: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial https://…

AC

a_chtung

@a_chtung · X

@TKapetanos @hotincleveland @ScientistSwanda how many participants is enough for you? 113? https://t.co/ODB0F4cqIt 152? https://t.co/ZDXEdB3cDH 1462? https://t.co/5BG7jvw3qh

AZ

Alan2102z

@alan2102z · X

@CentristJust @DarrellTank @hyperplanes @clairlemon https://t.co/wghGYURvE4

JL

jose luis lopera

@joseluislopera7 · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/Siwz8KUk8M

CC

Chai-chai

@yutan_1961 · X

RT @neznezxmail: @styh131582 最新情報ありがとうございます．フルボキサミンのRCTは昨年の⇩しか知らなかったのですが（当時驚きました），本邦の最大用量を超えるプロトコールだったので，用量も気になるところです． https://t.co/EthKxxv…

薫

薫

@yomogimochi771 · X

RT @neznezxmail: @styh131582 最新情報ありがとうございます．フルボキサミンのRCTは昨年の⇩しか知らなかったのですが（当時驚きました），本邦の最大用量を超えるプロトコールだったので，用量も気になるところです． https://t.co/EthKxxv…

M

meltypot

@meltypot · X

RT @neznezxmail: @styh131582 最新情報ありがとうございます．フルボキサミンのRCTは昨年の⇩しか知らなかったのですが（当時驚きました），本邦の最大用量を超えるプロトコールだったので，用量も気になるところです． https://t.co/EthKxxv…

?

136

@P15136 · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/jGufBqZBqK

呼

呼吸器内科医＠

@neznezxmail · X

@styh131582 最新情報ありがとうございます．フルボキサミンのRCTは昨年の⇩しか知らなかったのですが（当時驚きました），本邦の最大用量を超えるプロトコールだったので，用量も気になるところです． https://t.co/EthKxxvwQE

AM

Atoms&Molecules

@Michael37823933 · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/DcLfbXU7O8

TL

Terri Lewis

@terriblewis1 · X

RT @ColbenJill: @veryvirology US- We are using IVM + Luvox for treatment. (Have heard good things recently about Indomethicin, but haven’…

JF

Joel "Heart Prevention" Kahn MD, FACC

@drjkahn · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical T… https://t.co/X7HwXQD4bz @treatearly @Covid19Critical

彫

彫木

@CordwainersCat · X

新型コロナ治療目的の臨床試験でのフルボキサミン服用量ってどのくらいなのだろう？と思って検索してみたらとんでも無かった。 ＞Participants were randomly assigned to receive 100 mg of fluvoxamine (n = 80) or placebo (n = 72) 3 times daily for 15 days. https://t.co/HBrXFIKMWd

ID

Important Web domains

@WebImportant · X

People get better on this cheap Medication. https://t.co/luNhLWKKJq November 12, 2020 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial

ID

Important Web domains

@WebImportant · X

https://t.co/luNhLWKKJq NO ONE ON FLUVOXAMINE GOT SICKER November 12, 2020 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial

CS

Chris Street

@ChrisGStreet · X

#Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/z8uj4QwK6Q

SH

Sandro Herek

@sandroherek · X

@PauloStFlexa @PlutoCult @JovemPanNews https://t.co/PEfB762YFI

AK

AMARESH KUMAR

@amareshskumar · X

RT @ColbenJill: @veryvirology US- We are using IVM + Luvox for treatment. (Have heard good things recently about Indomethicin, but haven’…

H

happa

@umiyama_01 · X

RT @Invesdoctor: 外来COVID-19患者に対するフルボキサミン（ルボックス、デプロメール）は、その後の増悪ゼロという驚異的報告。 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients…

M

mani

@ManimuthiahMani · X

RT @RudolfUher: The best treatment for COVID-19 so far? An antidepressant? #fluvoxamine prevented significant deterioration and reduced adv…

T

TheKovaiCaveman

@TheKovaiCaveman · X

@malpani https://t.co/vhqtq3O8MF

?

/\/\ /\ /2 ¥

@sperhauoc · X

RT @Doctorxy2: @stkirsch @Covid19Crusher https://t.co/jNtHwdfNpc

NM

nelson marques

@nelson970726961 · X

RT @MedicineVilla: #Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic #COVID-19 https://t.co/UwTf5pf0uO

OH

Online Pharmacy Store in USA | Ivermectin | HCQS

@MedicineVilla · X

#Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic #COVID-19 https://t.co/UwTf5pf0uO

SA

Shah Abdullah

@ShahAbd36808740 · X

RT @drgsrao: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Crit…

HH

Hi Hyderabad

@HiHyderabad · X

RT @drgsrao: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Crit…

M

Mahabubnagar

@MahabubnagarO · X

RT @drgsrao: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Crit…

HR

Hamed Rizwan

@hamedRizwan99 · X

RT @drgsrao: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Crit…

IK

Irfan Khan

@IrfanKhanhyd · X

RT @drgsrao: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Crit…

DR

Dr. Gadala Srinivasa Rao

@drgsrao · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/hFeIsgQPbK

MS

Melissa Scott

@scott_lissa · X

RT @Doctorxy2: @stkirsch @Covid19Crusher https://t.co/jNtHwdfNpc

SY

Sağlıklı Yaşam

@saglikyrehberi · X

@stkirsch @Covid19Crusher https://t.co/jNtHwdfNpc

AC

a_chtung

@a_chtung · X

@PoltWhite @OlgaVPettersson https://t.co/ZDXEdB3cDH

RN

Rodrigo Nahum

@betagamizado · X

4) Fluvoxamina: https://t.co/WDxZn6wuiM 5) Hidroxicloroquina e azitromicina: https://t.co/arDoiBYFSG https://t.co/JO1VrHdjnm 6) Zinco e/ou Vitamina C: https://t.co/L9vpTZGJlB 6b) Estado nutricional: https://t.co/mvsQTrHKw7 7) Peginterferon lambda: https://t.co/kXLFEmTbUW ...

JC

Jess Clarke

@JessClarke007 · X

@veryvirology US- We are using IVM + Luvox for treatment. (Have heard good things recently about Indomethicin, but haven’t used yet) OTC’s we like: Vit D, NAC, Niacin, Zinc, Melatonin https://t.co/B854qf1e8U https://t.co/6sjofsqSxC

ギ

ギャチュンカン

@KhumbuHimal · X

RT @Invesdoctor: 外来COVID-19患者に対するフルボキサミン（ルボックス、デプロメール）は、その後の増悪ゼロという驚異的報告。 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients…

T

teukuleft

@aliancanobre · X

RT @SspeedBrasil: @g1 Deixo aqui aos jornalistas e reporteres acéfalos algumas coisinhas. RCT revisado por pares e publicado. Nitazoxanida…

C

Claudião ®️

@SspeedBrasil · X

@g1 Deixo aqui aos jornalistas e reporteres acéfalos algumas coisinhas. RCT revisado por pares e publicado. Nitazoxanida https://t.co/Az73hoXUgU Fluvoxamina https://t.co/GrdC1AsjmJ Dutasterida https://t.co/Nlh0xBwx5a Proxalutamida https://t.co/L1bHSuRi0o

C

Claudião ®️

@SspeedBrasil · X

@marceloramosam RCT revisado por pares e publicado Nitazoxanida https://t.co/N1CRFCvO8b Fluvoxamina https://t.co/MBk74VNSGh Dutasterida https://t.co/Iq6blWzlQc Proxalutamida https://t.co/7elqO2fUEH HCQ + Colchicina https://t.co/3nHRCDprYX Bromexina https://t.co/uksatu7vxn

ME

Medical Science and Technology #earlytreatments

@MedicalScitech · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 » https://t.co/P1iyqgCwgc Does #fluvoxamine, a selective serotonin reuptake inhibitor and σ-1 receptor agonist prevent clinical deterioration in outpatients with acute #COVID19? To be cont. https://t.co/lYHog2zv8U

CL

capinando um lote

@RafaelF038 · X

@susanesantos13 @TaiLung2X @GeneralMourao https://t.co/Lbqd0M17a4

CC

Claudia Costa

@ClaudiaCLiberty · X

RT @MarcJMor: @realpfigueiredo Há dezenas de alternativas e trabalhos científicos, para desespero dos #CoronaLovers Nitazoxanida https://t…

MB

Márcio Brasil

@MarcJMor · X

@realpfigueiredo Há dezenas de alternativas e trabalhos científicos, para desespero dos #CoronaLovers Nitazoxanida https://t.co/MvjZBWRGB9 Fluvoxamina https://t.co/9yjNTSqVpw Dutasterida https://t.co/zkdevwdoyB Proxalutamida https://t.co/aqtjgMKf33 HCQ + Colchicina https://t.co/dhYjPrLrBR

K

kithercbaby

@kithercbaby · X

@FenderB70494747 Another inexpensive drug that Big Pharma can't make the big bucks on. I found this trial with Fluvxamine promising: https://t.co/59OP4t9f0y In England, they've had great success with Ivermectin, doxycycline and zinc as well.

LA

Liane Alves

@LianeASousa · X

@mdsjotave @ElZorroRjo @Fasalles Vários trabalhos científicos sobre tratamento do covid. Só não sabe quem não estuda. Nitazoxanida https://t.co/gLttR65i6l Fluvoxamina https://t.co/FIpAwgDxBo Dutasterida https://t.co/3Yar9RNhxj Proxalutamida https://t.co/Yy4zVVMAdB HCQ + Colchicina https://t.co/1Q7PYtdRXV

NT

NA-TAXA

@NAH_TAXA · X

RT @MoneVieiraFoka: Vários trabalhos científicos sobre tratamento do covid. Só não sabe quem não estuda. Nitazoxanida https://t.co/pjFK5MZ…

F

Folhaovento

@Folhaovento · X

RT @MoneVieiraFoka: Vários trabalhos científicos sobre tratamento do covid. Só não sabe quem não estuda. Nitazoxanida https://t.co/pjFK5MZ…

L

Luciane

@LucianeSerra77 · X

RT @MoneVieiraFoka: Vários trabalhos científicos sobre tratamento do covid. Só não sabe quem não estuda. Nitazoxanida https://t.co/pjFK5MZ…

MV

Mone Vieira

@MoneVieiraFoka · X

Vários trabalhos científicos sobre tratamento do covid. Só não sabe quem não estuda. Nitazoxanida https://t.co/pjFK5MZxMz Fluvoxamina https://t.co/WAOfqr2Pwj Dutasterida https://t.co/7Lj3dmUdYY Proxalutamida https://t.co/jAhyQFb3vP HCQ + Colchicina https://t.co/r9iUpLj3Xf

AS

Afonso Celso e Simone

@AfonsoC27537254 · X

e, óbvio, quanto mais precoce agirmos terapêuticamente, maior chance de sucesso! Nitazoxanida https://t.co/UlHrwai2Zo Fluvoxamina https://t.co/nGaaeeJSQz Dutasterida https://t.co/8GM2bFZzOK Proxalutamida https://t.co/Q2XK3xo00s HCQ + Colchicina https://t.co/iDgR2XbvZP

C

c410

@c410 · X

@Igorvieira_1 @drexihouis @JornalOGlobo Fluvoxamina vs Placebo e deterioração clínica em pacientes ambulatoriais com COVID-19 sintomático: um ensaio clínico randomizado https://t.co/dM8HbOuxC6

CV

Cristo vive!

@FabiannaManzur · X

@marceloramosam Dizem os “especialistas” da mídia necrófila: “Não existe tratamento. Só vale RCT revisado por pares e publicado”. OK! Nitazoxanida https://t.co/3xJab1HrXg Fluvoxamina https://t.co/YdxXuDJSlA Dutasterida https://t.co/o87MwLTPtv Proxalutamida https://t.co/h3NfGndr96 ⏬

JT

Jacinta Toledo

@JacintaToledo · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial - PubMed https://t.co/5ffs0TAgiH

P

PrLantern

@PrLantern · X

RT @PrLantern: @Medecinemadd @anne_gens @Dr_moji Non ces pays suivent certaines pistes dont la #fluvoxamine qui a montré une efficacité imp…

P

PrLantern

@PrLantern · X

@Medecinemadd @anne_gens @Dr_moji Non ces pays suivent certaines pistes dont la #fluvoxamine qui a montré une efficacité importante dans plusieurs travaux préliminaires dont cette étude publiée en 2020 dans le JAMA : https://t.co/7hRgnaVTUe (1/2)

BL

Bradley Jaffe, LCSW

@BeeradJaffe · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/7aQFebmiFF

A

araguaci

@araguaci · X

Maratona de Estudos 2/15 #Fluvoxamina vs Placebo e deterioração clínica em pacientes ambulatoriais com COVID-19 sintomático: um ensaio clínico randomizado https://t.co/hbgavfCEoU

RA

Ricardo_AVB78

@Ricardo_AVB78 · X

@UrsoCantor Achei os "estudos" tao soltando por ai. Pelo q eu vi no "resumo" deles, é bem inconclusivo. Nitazoxanida https://t.co/8GxKlaf4od Fluvoxamina https://t.co/W592F9BEj6 Dutasterida https://t.co/G6vlhePWrf

LM

Luciana Mendes

@LMMAGLIANO · X

Dizem os “especialistas” da mídia necrófila: “Não existe tratamento. Só vale RCT revisado por pares e publicado”. OK! Nitazoxanida https://t.co/pv2Xa1zbsZ Fluvoxamina https://t.co/QgN3M0HZ6O Dutasterida https://t.co/9QwzlFJSUI Proxalutamida https://t.co/p8D28eKTuq

SP

Sonia Passos

@soniaspassos · X

@CNNBrasil Dizem os “especialistas” da mídia necrófila: “Não existe tratamento. Só vale RCT revisado por pares e publicado”. OK! Nitazoxanida https://t.co/H8ya89e8uh Fluvoxamina https://t.co/R188lBvmUc Dutasterida https://t.co/SfKl09u8Ni Proxalutamida https://t.co/7l0Sxzfw28

DC

Dan Castro

@DanCas2 · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network - https://t.co/r9y5EZRPiw

DM

DMcKinney, MSN

@napernurse · X

#Fluvoxamine vs Placebo and Clinical Deterioration in #Outpatients With Symptomatic #COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network #MedTwitter #RCT https://t.co/A0oVaFcCUH

YZ

yar zuk

@yarzuk · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/uRVKNQhebW

MD

Martin Duenas

@duenasm85 · X

#Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic #COVID-19: adult outpatients with symptomatic COVID-19, patients treated with fluvoxamine, compared with placebo, had a lower likelihood of clinical…https://t.co/WY38rNgTJG https://t.co/K66oAqm5f6

F

Fernando

@Chapermann · X

@jeffs_araujo35 Estou cético em relação a anti depressivos.... Prefiro acompanhar esse: https://t.co/CINui2Axqy Do que esse: https://t.co/5lO3MQPJLt

J

JOVI

@jovismith · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/lKdILz5sb8

B

Buddy

@BuddyMcDuff · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/5g72tIx8QK

PV

Paula Vaughn

@ICPaulaVaughn · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/cqt9QR0wHA

D

drklausner

@drklausner · X

RT @RichardALoftus1: @DrMattMcCarthy The studies on fluvoxamine, posited to reduce inflammatory response/cellular stress by sigma-1 recepto…

P

PrLantern

@PrLantern · X

@Covid19Crusher Also the positive RCT published in the JAMA : https://t.co/7hRgnaVTUe

RM

Richard A. Loftus MD

@RichardALoftus1 · X

@DrMattMcCarthy The studies on fluvoxamine, posited to reduce inflammatory response/cellular stress by sigma-1 receptor agonism, may offer a more selective option. JAMA.2020;324(22):2292-2300. doi:10.1001/jama.2020.22760 Eur Arch Psychiatry Clin Neurosci (2021). https://t.co/H9Psvp642y

RM

Richard A. Loftus MD

@RichardALoftus1 · X

... proteins in the endoplasmic reticulum. See Lenze et al JAMA. JAMA. 2020;324(22):2292-2300. doi:10.1001/jama.2020.22760

I

#ivermectin

@ivermectin_jpn · X

RT @EARL_COVID19_tw: 急性呼吸促迫症候群による入院ではない発症から7日以内の成人新型コロナウイルス感染症患者に対するフルボキサミン投与はプラセボに比して症状増悪を有意に抑制した．152例DB-RCT（JAMA 2020, Nov12） https://t.c…

S

shiroro

@shiroro75961128 · X

RT @EARL_COVID19_tw: 急性呼吸促迫症候群による入院ではない発症から7日以内の成人新型コロナウイルス感染症患者に対するフルボキサミン投与はプラセボに比して症状増悪を有意に抑制した．152例DB-RCT（JAMA 2020, Nov12） https://t.c…

E

EllieJellie2020

@EllieJellie2020 · X

@Parsifaler Perhaps why Fluvoxamine helps in severe C19 disease. Also have you seen those comments about respiratory deterioration in severe Covid being seratonin syndrome? https://t.co/UQT7Sizjyb

P

PrLantern

@PrLantern · X

@Julbert86 @SimonneauJoelle @raoult_didier Ok mais prometteur vous en conviendrez. 2° le papier dans le JAMA : https://t.co/7hRgnaVTUe

原

原発はいますぐ廃止せよ

@kokikokiya · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical T… https://t.co/aoUHhR0B6X 症候性COVID-19の外来患者におけるフルボキサミン対プラセボおよび臨床的悪化：無作為化臨床試験

J

JAMA

@JAMA_current · X

RT @WUICTS: Publications above include #WUICTS investigators and their research, "Fluvoxamine vs Placebo and Clinical Deterioration in Outp…

S

Sam

@CriticalCareSam · X

@McLoughlinSarah @Jopo_dr In a preliminary trial SSRI's are protective against severe covid when taken long term prior to infection. SSRI's inhibit the platelet 5-HT transporter so when activated, don't release 5-HT, less platelet aggregation, less clotty badness https://t.co/pjVtJHle0B

C

CogniSphere

@jorgensenmc1 · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/uWXqa4P1V5

IS

ICTS @ WashU in STL

@WUICTS · X

Publications above include #WUICTS investigators and their research, "Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial" published in @JAMA_current Nov. 11, 2020. #CTSAProgram

PL

Psy-lyon

@cialdella01 · X

@psy_massondavid @Littherapeute En dehors de cette petite étude https://t.co/iDO2pYWQSD

P

PrLantern

@PrLantern · X

@LoloB09196040 @samsagace34 @medicalfollower RCT publié dans le JAMA récemment qui montre l'efficacité de la #Fluvoxamine pour soigner la #COVID19 https://t.co/7hRgnaVTUe Vous me direz ce que vous en pensez.

P

PrLantern

@PrLantern · X

@TristanBertin @PoloSven @fquedeville https://t.co/7hRgnaVTUe Publié dans le JAMA

P

PrLantern

@PrLantern · X

@PoloSven @fquedeville https://t.co/7hRgnaVTUe Publié dans le JAMA, pas mal non ?

KG

Ken Gusler

@kgusler · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial - https://t.co/p6swfbxtxe

NM

Ndabuko ka Malindi

@MalindiMcd · X

RT @realTholo: @LetlapaMphahlel Here is a study on Luvox: an antidepressant that is cheaply available that could help with Covid. JAMA. 20…

TN

Tholo (praise name)

@realTholo · X

@LetlapaMphahlel Here is a study on Luvox: an antidepressant that is cheaply available that could help with Covid. JAMA. 2020;324(22):2292-2300. doi:10.1001/jama.2020.22760 https://t.co/77FVnBQlFD

総子

総合診療医・家庭医masa【子育てに悩むパパ医】

@nextmasa1 · X

軽症コロナ（SpO2>92%）に対し、選択的セロトニン再取り込み阻害薬のフルボキサミンが臨床的悪化を抑制。 臨床的悪化が投与群は80例中0例、プラセボ群72例中6例。 https://t.co/UdRaAxkJY3 ＃積み上げ　＃コロナ　＃論文

S

sam

@elizabethinALa · X

RT @NG20194: @abledoc @__ice9 @farid__jalali @AskDrShashank Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…

DJ

Dr. Shashank Joshi

@AskDrShashank · X

RT @NG20194: @abledoc @__ice9 @farid__jalali @AskDrShashank Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…

ود

ووٹ کو عزت دو

@Mu7ibullah · X

RT @NG20194: @abledoc @__ice9 @farid__jalali @AskDrShashank Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…

N

NG20194

@NG20194 · X

@abledoc @__ice9 @farid__jalali @AskDrShashank Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial https://t.co/55SmizQaKB

A

Alejandro

@dronico · X

RT @drakchaurasia: FLUVOXAMINE IN ACUTE COVID fluvoxamine, an option to places where other anticovid not available "Fluvoxamine vs Placebo…

DC

dr a k chaurasia

@drakchaurasia · X

FLUVOXAMINE IN ACUTE COVID fluvoxamine, an option to places where other anticovid not available "Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19" https://t.co/9CCOnvm5X8(COVID,receptor%2C%20which%20regulates%20cytokine%20production.

IM

Ilija Srdanović MD

@ilijasrdNS · X

RT @ogi_gajic: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial htt…

OG

Ognjen Gajic

@ogi_gajic · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial https://t.co/JpDxcNOzZJ

EM

Ernesto de Bernardis, MD

@debe · X

@stkirsch I know of this contactless RCT https://t.co/uvpDJiDHJ7 Are there more which went out of my radar? Thanks

DM

Don De Tina MD

@donnyd · X

RT @donnyd: @DrJohnAquino I saw that POEM today too! https://t.co/BWIYJxESQf

DM

Don De Tina MD

@donnyd · X

@DrJohnAquino I saw that POEM today too! https://t.co/BWIYJxESQf

PD

Paul Dark

@DarkNatter · X

@iceman_ex @iamyourgasman @ThinkingCC @karenkempsell1 @remap_cap @WWIEM_QUB @dfmcauley I'm aware of this hypothesis generating study in mild/moderate #Covid_19 https://t.co/4yf2y9oIfg - not come through our hands as RCT yet in severe

SM

Səbrin Musayev

@GovoritPini · X

@obabeylik + Antidepresan olan fluvoxamine'nin bazı hastaların kötüleşmesinin 15 gün içersinde önüne geçmiş. İlacı alanların hepsinde işe yaramış. 2 güzel haber daha. https://t.co/6KHRHcljGR

P

Parcero

@pseudolangui · X

Ojo aquí amigos médicos, esto ha sido más "benéfico" que lo que están recetando muchos para paciente ambulatorio con COVID19 (ivermectina, azitromicina, hidroxicloriquina, etc.). Estudio de población pequeña pero me parece súper interesante ¿Qué opinan?

LI

Lazar Ilchev

@IlchevLazar · X

RT @NeBirgitta: @BillyBostickson just find - pleas spread German scientists came to the same result - fluvoxamine has the same effect as I…

F

@Flohchen_19

@Flohchen_19 · X

RT @NeBirgitta: @jutta_ditfurth @GEGENCovidioten Was noch unglaublicher ist, dass unsere Universitäten auf Almosen der Pharmaindustrie ange…

F

@Flohchen_19

@Flohchen_19 · X

RT @NeBirgitta: @Robert83563198 @GEGENCovidioten @Karl_Lauterbach @BioNTech_Group das mit den Versuchen, die es werte wäre weiter verfolgt…

J

JusticeForAll

@AmericaJust · X

RT @binaryanalogue: A4: Fluvoxamine, an SSRI, stopped clinical progression in symptomatic COVID-19 patient. No Ab data. SSRIs lower prod…

BN

Birgitta Neher

@NeBirgitta · X

@jutta_ditfurth @GEGENCovidioten Was noch unglaublicher ist, dass unsere Universitäten auf Almosen der Pharmaindustrie angewiesen sind um forschen zu können. Uni Würzburg bekommt keine Mittel für diese Forschung seit Juni!! Hier Arbeit aus der USA aus Dezember https://t.co/EThLQnWNOF

BN

Birgitta Neher

@NeBirgitta · X

@Robert83563198 @GEGENCovidioten @Karl_Lauterbach @BioNTech_Group das mit den Versuchen, die es werte wäre weiter verfolgt zu werden ist so eine Sache... hier eine Beispiel - weitere Arbeiten in Deutschland nicht möglich - weil keine Mittel zur Verfügung stehen -UNI Würzburg - ich gehe sammeln hier USA vom 08.12. https://t.co/EThLQnWNOF

TO

THE OLAOSEGBA

@THEOLAOSEGBA · X

RT @neuropsychblog: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic #COVID19 - A Randomized Clinical Tria…

N

Neuropsychology

@neuropsychblog · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic #COVID19 - A Randomized Clinical Trial https://t.co/wnG8ED62IQ

BB

Billy Bostickson

@BillyBostickson · X

RT @NeBirgitta: @BillyBostickson just find - pleas spread German scientists came to the same result - fluvoxamine has the same effect as I…

DA

Dr Sufian Arshad

@DrSufCh · X

RT @NeBirgitta: @DrSufCh important ! German scientists came to the same result - fluvoxamine has the same effect as Imipramine against viru…

BN

Birgitta Neher

@NeBirgitta · X

@DrSufCh important ! German scientists came to the same result - fluvoxamine has the same effect as Imipramine against viruses - IMPORTANT counteracts sepsis among other things! https://t.co/EThLQnWNOF

BN

Birgitta Neher

@NeBirgitta · X

@BillyBostickson just find - pleas spread German scientists came to the same result - fluvoxamine has the same effect as Imipramine against viruses - IMPORTANT counteracts sepsis among other things! https://t.co/EThLQnWNOF

NU

NK Leb #UpdateTheVaccines

@NickytaLeb · X

RT @binaryanalogue: A4: Fluvoxamine, an SSRI, stopped clinical progression in symptomatic COVID-19 patient. No Ab data. SSRIs lower prod…

W

Wil

@binaryanalogue · X

A4: Fluvoxamine, an SSRI, stopped clinical progression in symptomatic COVID-19 patient. No Ab data. SSRIs lower production of inflammatory cytokines, including TNF. No other data found on SSRIs and COVID-19 severity. https://t.co/Uq2OmlPWHr Study: https://t.co/fCU6m5tGpf

DS

Dr.Gamze Sisman

@gamzesisman · X

RT @DrGunerSonmez:

AB

AYŞE BiLGEN

@AYSGL_BLGN · X

RT @DrGunerSonmez:

A

Aposkal

@tweetkaradeniz · X

RT @DrGunerSonmez:

AK

Asuman Fatma KAPLAN

@doktoru_cep · X

RT @DrGunerSonmez:

AÖ

Azime Ö.

@ozkayaazime · X

RT @DrGunerSonmez:

A

anne

@gldren6 · X

RT @DrGunerSonmez:

PC

PD Dr. Prashant Chhajed

@prashantchhajed · X

Adult outpatients with symptomatic COVID-19, patients treated with fluvoxamine, compared with placebo, had a lower likelihood of clinical deterioration over 15 days ⁦@JAMA_current⁩ ⁦@JAMANetworkOpen⁩ https://t.co/VGcPsymlvy

Ş

şebnem

@ebnem15090157 · X

RT @DrGunerSonmez:

UT

umit tursen

@utursen · X

RT @DrGunerSonmez:

MD

Mehmet Ali Dundar

@DrMAliDundar · X

RT @DrGunerSonmez:

NY

nergis yücekaya

@nergisycekaya · X

RT @DrGunerSonmez:

I

irem

@irem33107929 · X

RT @DrGunerSonmez:

I

isaaahishali

@isaaahishali1 · X

RT @DrGunerSonmez:

ÖU

ömer seyfettin uslu

@radomerus · X

RT @DrGunerSonmez:

M

mesut

@mesutcor · X

RT @DrGunerSonmez:

CN

Chucky'ninGelini

@kelebeik · X

RT @DrGunerSonmez:

S

ss

@ss343541 · X

RT @DrGunerSonmez:

TK

T.kimura

@jjcrazydiamond · X

RT @JAMA_current: In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterior…

K

karakız

@kutadgubilik · X

RT @DrGunerSonmez:

ÖD

Önemli değil

@birisi2021 · X

RT @DrGunerSonmez:

M

Mahpeyker

@Mahpeyk27927946 · X

RT @DrGunerSonmez:

H

Hndntny

@hndntny · X

RT @DrGunerSonmez:

M

Moonangel

@iek15166790 · X

RT @DrGunerSonmez:

NM

norma mia

@normamia4 · X

RT @DrGunerSonmez:

A

Albatrosminerva

@albatrosminerva · X

RT @DrGunerSonmez:

YD

Yalçın Daştan

@yalcindastan · X

RT @DrGunerSonmez:

K

Kerem

@Kerem56730951 · X

RT @DrGunerSonmez:

C

CngzhnevranAk

@CngzhnevranAk · X

RT @DrGunerSonmez:

EU

enver uysal

@korbay10 · X

RT @DrGunerSonmez:

AG

ahmet gümüştekin

@agumustekin · X

RT @DrGunerSonmez:

KB

kazan bulut

@supurenci · X

RT @DrGunerSonmez:

N

niyankara

@niyankara · X

RT @DrGunerSonmez:

WÖ

Woody Woodpecker (Ekrem İmamoğlu özgürlük)

@Benekonomistktm · X

RT @DrGunerSonmez:

MS

Murat Sert

@MuratSert0101 · X

RT @DrGunerSonmez:

G

GRPNR

@bsgurpinar · X

RT @DrGunerSonmez:

G

Gül

@Glretmen3 · X

RT @DrGunerSonmez:

NB

Neri 1903BJK

@Neriman1903BJ · X

RT @DrGunerSonmez:

AA

Av.Arb.Habip Akhan

@habipakhan · X

RT @DrGunerSonmez:

B

Biserka

@bahtenengin · X

RT @DrGunerSonmez:

AL

ab ira leonis

@jytienspas · X

RT @JAMA_current: In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterior…

SM

Santosh Murthy

@san_murthy · X

RT @JAMA_current: In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterior…

AS

Abdullah SA

@abaaaadi2012 · X

RT @JAMA_current: In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterior…

CM

Chris Manzella

@ChrisRManzella · X

RT @JAMA_current: In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterior…

AE

Abu Emmil

@abu_emmil · X

RT @JAMA_current: In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterior…

VP

Villahermosa se vistió de fiesta con la primavera

@Gust_1971 · X

RT @JAMA_current: In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterior…

CC

catia cilloniz

@CatiaCilloniz · X

RT @JAMA_current: In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterior…

KM

Kirk Murphy

@kirkmurphy · X

RT @JAMA_current: In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterior…

C

Constance

@jconstance61 · X

RT @JAMA_current: In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterior…

PM

Pub Health Monitor

@monitor_PH · X

RT @JAMA_current: In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterior…

J

JAMA

@JAMA_current · X

In this preliminary RCT adult outpatients w symptomatic #COVID19 treated w fluvoxamine had a lower likelihood of deterioration over 15 days vs placebo. However, the study is limited by a small sample size & short follow-up https://t.co/XPnsd0YrJ8

SM

Sean C. Lucan, MD

@SeanLucan · X

Small sample. Short follow up. Nonetheless, promising result - unlike #Hydroxychloroquine trials (I'll confess, I had never even heard of a sigma receptor ... & never would have thought of an SSRI for #COVID19 treatment) https://t.co/qGUaW8ouRA via @JAMA_current https://t.co/14Cdfq5Iq7

A

aeon

@AeonCoin · X

@tomvdb @VinnyLingham That's only one of two claims being made though. The other one appears more credible: https://t.co/oiXEVmproy https://t.co/AAxpXFW6bh

J

jpreventionalzheimer

@jpreventionalz1 · X

RT @brunovellas: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial |…

BV

Bruno Vellas

@brunovellas · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/AvVRWZ1LL4

R

RotherhamNHSLibrary

@RotherhamNHSLib · X

JAMA: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial #covid19rftlks https://t.co/U4jT75sSFJ

FA

Farmacia Madrid AP

@FarmaMadridAP · X

(JAMA) Everto de fluvoxamina vs placebo en el deterioro clínico en pacientes ambulatorios con COVID-19 https://t.co/tTEiPL03Gi

C

Crr1114

@crr1114 · X

So much bluster on HCQ yet a tidy little RCT on fluvoxamine flies under the radar: https://t.co/ZTxxh9o6uz

L

Lucie

@TumbyWallop · X

@jameshamblin And maybe (small study) this could help with both depression and milder cases of Covid19. https://t.co/0lx9NzpD69

SL

Scott Leibrand

@scottleibrand · X

RT @KarenRylander: Small trial shows possible strong effect of antidepressant on preventing COVID hospitalization: https://t.co/mw1WuoHiuC

KR

Karen Rylander

@KarenRylander · X

Small trial shows possible strong effect of antidepressant on preventing COVID hospitalization: https://t.co/mw1WuoHiuC

不

不言実行なのだ!!!!!!!☺︎

@2003jpLove2m · X

RT @Newcli0: ＼研究段階にあるものを治療に使用してしまう行き過ぎ感／ 治験のことですか?www 感染症と抗精神薬に詳しいデマ屋 #すけろく おじさん、SSRIで面白い報告が出てますよ。@2012wat Fluvoxamine vs Placebo and Clini…

ニ

ニュークリ

@Newcli0 · X

＼研究段階にあるものを治療に使用してしまう行き過ぎ感／ 治験のことですか?www 感染症と抗精神薬に詳しいデマ屋 #すけろく おじさん、SSRIで面白い報告が出てますよ。@2012wat Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 https://t.co/AsqI6fNDO5 https://t.co/UGQKPsPkkn

O

ossanpower2016

@ossanopwer2016 · X

σ1受容体アゴニストである選択的セロトニン再取り込み阻害薬（SSRI）のフルボキサミンがCOVID-19の重症化を抑制する可能性が示された https://t.co/3s3AHjNFkB 症候性COVID-19成人患者を対象, プラセボ群と比べてフルボキサミン群では15日後の重症化リスクが低かった。

小P

小嶋 慎二＠community pharmacist

@kojima_aponet · X

RT @kojima_aponet: 【JAMA. Nov 12 2020】 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomi…

ピ

ピノハル

@pinoharu1 · X

抗うつ薬がコロナに卓効？　うつ治療と一石二鳥 https://t.co/MHHB2Pajf3

ぷ

ぷしのすけ

@PsyDocFujy · X

https://t.co/Zf5zUCc2bn えー！？ これはこれであまり有名になって欲しくない事象ですな、精神科医としては。 それ目的の処方はちょっと……。

原

原発はいますぐ廃止せよ

@kokikokiya · X

» Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/F58reu0FX3

ミ

ミヤイリGUY

@Robson_1915 · X

σ-1受容体刺激で新型コロナの症状悪化抑制とかいう論文が出たからって調子に乗ってやがる…。 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial https://t.co/bZ65wDgCRG

P

PsicosexologaM

@PsicosexologaM · X

Transcribo...UN ANTIDEPRESIVO, LA FLUVOXAMINA AYUDA A PREVENIR EL DETERIO EN PACIENTES CON COVID-19 Según un estudio reciente (Lenze y col. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients with Symptomatic COVID-19: A Randomized..

S

Silentsniper

@Silent_Sniper1 · X

RT @drcadesky: Could SSRI antidepressants help treat #COVID? There is a plausible mechanism, but more studies are needed https://t.co/1R6sf…

SM

Savvas Nicolaou, MD

@EmergTraumaRad · X

RT @drcadesky: Could SSRI antidepressants help treat #COVID? There is a plausible mechanism, but more studies are needed https://t.co/1R6sf…

EM

Eric Cadesky MD

@drcadesky · X

Could SSRI antidepressants help treat #COVID? There is a plausible mechanism, but more studies are needed https://t.co/1R6sfyeQPI @drmattchow @JD_Rosenblat

RD

Ruslan Dorfman

@RuslanDorfman · X

RT @mueller_dj: Interesting & consistent w/ this nottion is this now published trial "Fluvoxamine vs Placebo and Clinical Deterioration in…

N

nevboard

@nevboard · X

Small numbers in this Missouri but worthy of a larger study of Fluvoxamine. Preventing Deterioration following COVID infection is deserving of good science. Thanks ⁦@JAMA_current⁩ #patientsafety https://t.co/CylsF7az2f

YG

yumi ＠gj

@ygjumi · X

RT @ygjumi: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial https://…

AM

Andreas Menke

@Dr_A_Me · X

RT @mueller_dj: Interesting & consistent w/ this nottion is this now published trial "Fluvoxamine vs Placebo and Clinical Deterioration in…

LM

Luis Mariani

@luismariani · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 https://t.co/r3LBZ38PYC

IC

Ich rede jetzt! Corinna

@an_corinna · X

RT @mueller_dj: Interesting & consistent w/ this nottion is this now published trial "Fluvoxamine vs Placebo and Clinical Deterioration in…

DM

Daniel J. Mueller

@mueller_dj · X

Interesting & consistent w/ this nottion is this now published trial "Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial" showing that the SSRI fluvoxamine was protective against COVID-19! https://t.co/gkLHePurut https://t.co/JFuh6H65eF

YG

yumi ＠gj

@ygjumi · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial https://t.co/ngPFxr9UTK

NM

Nan Raghuraman MD MSCI

@NanRaghuraman · X

Promising results from this RCT performed at ⁦@WUSTLmed⁩ that included pregnant patients! A shining example for others. #dontexcludepregnancy Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 https://t.co/27SYG245Sy

GÁ

Gary Álvarez.•.

@garinho29 · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/kVZF2MYoiT

ME

Montse Esquerda

@montse_esquerda · X

Solo sé que no sé nada... Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial @JAMA_current part of @JAMANetwork https://t.co/LP1pN6gQDv

O

Omero

@Omeroblu · X

RT @Pinzie: This. https://t.co/cSDnBAgIqI

M

Matt

@Pinzie · X

This. https://t.co/cSDnBAgIqI

EM

Emilio Mordini

@emiliomordini · X

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network | @scoopit https://t.co/bwvvZ4Dx9m

T

tuikoku

@tuikoku · X

RT @Invesdoctor: 外来COVID-19患者に対するフルボキサミン（ルボックス、デプロメール）は、その後の増悪ゼロという驚異的報告。 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients…

JP

Jack9pk

@jack9pk · X

RT @Invesdoctor: 外来COVID-19患者に対するフルボキサミン（ルボックス、デプロメール）は、その後の増悪ゼロという驚異的報告。 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients…

さ

さてつ

@press_cub_blue · X

RT @Invesdoctor: 外来COVID-19患者に対するフルボキサミン（ルボックス、デプロメール）は、その後の増悪ゼロという驚異的報告。 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients…

GD

George Dawson

@dawso007 · X

@cadoganhealthc1 @wendyburn See also: Lenze EJ, et al. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial. JAMA. 2020 Nov 12:e2022760. doi: 10.1001/jama.2020.22760. Epub ahead of print. PMID: 33180097; PMCID: PMC7662481.

RY

rize-y

@rizey07 · X

RT @Invesdoctor: 外来COVID-19患者に対するフルボキサミン（ルボックス、デプロメール）は、その後の増悪ゼロという驚異的報告。 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients…

ST

Science Will Triumph

@giunbia · X

Credo che anche la fluvoxamina verrà accantonata #Covid_19 https://t.co/ETjFUoNwGS

わｶ

わか❄️(｢ﾟДﾟ)｢ｶﾞｳｶﾞｳ

@wakachuki · X

RT @influenzer3: 抗炎症作用が作用機序として推定されているようです。 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Rand…

E

ete

@ete48318089 · X

RT @influenzer3: 抗炎症作用が作用機序として推定されているようです。 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Rand…

NM

Neil Floch MD

@NeilFlochMD · X

RT @RIGHT_COVID19: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic #COVIDー19: A Randomized Clinical Trial…

ボ

ボムアルケミスト

@TAK178_923 · X

RT @Invesdoctor: 外来COVID-19患者に対するフルボキサミン（ルボックス、デプロメール）は、その後の増悪ゼロという驚異的報告。 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients…

ア

アニオタ

@Dsi27sUhh9SR7YF · X

RT @Invesdoctor: 外来COVID-19患者に対するフルボキサミン（ルボックス、デプロメール）は、その後の増悪ゼロという驚異的報告。 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients…

AB

Alessandra Borsini

@ABorsini · X

RT @RudolfUher: The best treatment for COVID-19 so far? An antidepressant? #fluvoxamine prevented significant deterioration and reduced adv…

VM

Valeria Mondelli

@MondelliValeria · X

RT @RudolfUher: The best treatment for COVID-19 so far? An antidepressant? #fluvoxamine prevented significant deterioration and reduced adv…

RU

Rudolf Uher

@RudolfUher · X

The best treatment for COVID-19 so far? An antidepressant? #fluvoxamine prevented significant deterioration and reduced adverse events in a study of 152 with COVID-19 infection. https://t.co/vz6eChugbS

横

横山暁子

@yokoakipp · X

RT @89089314: なん……だと……(; ･`д･´) フルボキサミン300mgが新コロの重症化を抑制したァ！？ Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…

鯖さ

鯖猫◇さばネコ

@saba0078 · X

RT @89089314: なん……だと……(; ･`д･´) フルボキサミン300mgが新コロの重症化を抑制したァ！？ Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…

クY

クロマ@5y

@chroma1125 · X

RT @89089314: なん……だと……(; ･`д･´) フルボキサミン300mgが新コロの重症化を抑制したァ！？ Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…

パ牡

パン焦がし薬剤師(やっちゃん)@牡丹山薬局

@yo_ishii_2021 · X

RT @89089314: なん……だと……(; ･`д･´) フルボキサミン300mgが新コロの重症化を抑制したァ！？ Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…

青発

青島周一@【書籍】「生成AIと学ぶ医学論文の読み方・考え方」発売中！

@syuichiao89 · X

RT @89089314: なん……だと……(; ･`д･´) フルボキサミン300mgが新コロの重症化を抑制したァ！？ Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…

ス

スケッチィ

@Lateralus823 · X

RT @89089314: なん……だと……(; ･`д･´) フルボキサミン300mgが新コロの重症化を抑制したァ！？ Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…

キ

キレイナオト

@Kireinaoto17 · X

RT @89089314: なん……だと……(; ･`д･´) フルボキサミン300mgが新コロの重症化を抑制したァ！？ Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…

バ

バウ

@bawdog · X

RT @89089314: なん……だと……(; ･`д･´) フルボキサミン300mgが新コロの重症化を抑制したァ！？ Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…

だ

だめんずでめんす

@damenzudemens · X

RT @89089314: なん……だと……(; ･`д･´) フルボキサミン300mgが新コロの重症化を抑制したァ！？ Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptoma…